A
A

Almirall

๊ฑฐ๋ž˜ ์•„์ด๋””์–ด

ํŠธ๋ ˆ์ด๋” ์‹ฌ๋ฆฌ

๊ธฐ์ˆ  ์š”์•ฝ

์‹œ๊ฐ„๋‹น

๋‰ด์Šค

Almirall rises after EMA's positive opinion on atopic dermatitis drug

BUZZ-Almirall rises after EMA's positive opinion on atopic dermatitis drug ** Almirall ALM.MC shares rise more than 3% after European Medicines Agency (EMA) issued a positive opinion for the authorization of EBGLYSS (lebrikizumab) to threat atopic dermatitis ** EMA's opinion is now being reviewed by the European Commission, with the approval of thi
A

Almirall Ebglyss (Lebrikizumab) Receives Positive CHMP Opinion For Moderate-To-Severe Atopic Dermatitis

BRIEF-Almirall Ebglyss (Lebrikizumab) Receives Positive CHMP Opinion For Moderate-To-Severe Atopic Dermatitis Sept 15 (Reuters) - Almirall SA ALM.MC : ALMIRALL EBGLYSS (LEBRIKIZUMAB) RECEIVES POSITIVE CHMP OPINION FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS THE POSITIVE CHMP OPINION IS NOW BEING REVIEWED BY THE EUROPEAN COMMISSION EXPECTS REGULATORY D
A

Almirall shares rise after buying rights for Alzheimer's product

BUZZ-Almirall shares rise after buying rights for Alzheimer's product ** Shares in Almirall ALM.MC rise more than 3% after the Spanish pharmaceutical group acquired rights for a product to treat Alzheimer's disease in Spain for 45 mln euros ($48.6 mln) ** The deal includes potential milestone payments of up to 15 mln euros ** Bankinter analysts say
A

Almirall Acquires Rights For An Alzheimer's Product In Spain

BRIEF-Almirall Acquires Rights For An Alzheimer's Product In Spain Sept 4 (Reuters) - Almirall SA ALM.MC : ACQUIRES RIGHTS FOR AN ALZHEIMERโ€™S PRODUCT IN SPAIN AGREEMENT GRANTS ALMIRALL EXCLUSIVE RIGHTS TRANSACTION HAS BEEN CLOSED FOR AN UPFRONT PAYMENT OF โ‚ฌ45MM PRODUCT IS A TRANSDERMAL PATCH WITH RIVASTIGMINE TO TREAT ALZHEIMERโ€™S DISEASE THIS
A

Spanish stocks - Factors to watch on July 24

Spanish stocks - Factors to watch on July 24 July 24 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: BBVA BBVA.MC The bank said on Friday it had decided to early redeem the issuance of preferred securities convertible into ordinary shares of BBVA on September 24. nL8N39A0TJ CAIXABANK CABK.MC Kruk unit said on Friday it bought 315 million euros of liabili
A
C
F
S

์กฐ๊ฑด

์ธ๊ธฐ ์ž์‚ฐ

๋ฉด์ฑ…์กฐํ•ญ: XM Group ํšŒ์‚ฌ๋Š” ์ฒด๊ฒฐ ์ „์šฉ ์„œ๋น„์Šค์™€ ์˜จ๋ผ์ธ ๊ฑฐ๋ž˜ ํ”Œ๋žซํผ์— ๋Œ€ํ•œ ์ ‘๊ทผ์„ ์ œ๊ณตํ•˜์—ฌ, ๊ฐœ์ธ์ด ์›น์‚ฌ์ดํŠธ์—์„œ ๋˜๋Š” ์›น์‚ฌ์ดํŠธ๋ฅผ ํ†ตํ•ด ์ด์šฉ ๊ฐ€๋Šฅํ•œ ์ฝ˜ํ…์ธ ๋ฅผ ๋ณด๊ฑฐ๋‚˜ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•ฉ๋‹ˆ๋‹ค. ์ด์— ๋Œ€ํ•ด ๋ณ€๊ฒฝํ•˜๊ฑฐ๋‚˜ ํ™•์žฅํ•  ์˜๋„๋Š” ์—†์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ ‘๊ทผ ๋ฐ ์‚ฌ์šฉ์—๋Š” ๋‹ค์Œ ์‚ฌํ•ญ์ด ํ•ญ์ƒ ์ ์šฉ๋ฉ๋‹ˆ๋‹ค: (i) ์ด์šฉ ์•ฝ๊ด€, (ii) ์œ„ํ—˜ ๊ฒฝ๊ณ , (iii) ์™„์ „ ๋ฉด์ฑ…์กฐํ•ญ. ๋”ฐ๋ผ์„œ, ์ด๋Ÿฌํ•œ ์ฝ˜ํ…์ธ ๋Š” ์ผ๋ฐ˜์ ์ธ ์ •๋ณด์— ๋ถˆ๊ณผํ•ฉ๋‹ˆ๋‹ค. ํŠนํžˆ, ์˜จ๋ผ์ธ ๊ฑฐ๋ž˜ ํ”Œ๋žซํผ์˜ ์ฝ˜ํ…์ธ ๋Š” ๊ธˆ์œต ์‹œ์žฅ์—์„œ์˜ ๊ฑฐ๋ž˜์— ๋Œ€ํ•œ ๊ถŒ์œ ๋‚˜ ์ œ์•ˆ์ด ์•„๋‹™๋‹ˆ๋‹ค. ๊ธˆ์œต ์‹œ์žฅ์—์„œ์˜ ๊ฑฐ๋ž˜๋Š” ์ž๋ณธ์— ์ƒ๋‹นํ•œ ์œ„ํ—˜์„ ์ˆ˜๋ฐ˜ํ•ฉ๋‹ˆ๋‹ค.

์˜จ๋ผ์ธ ๊ฑฐ๋ž˜ ํ”Œ๋žซํผ์— ๊ณต๊ฐœ๋œ ๋ชจ๋“  ์ž๋ฃŒ๋Š” ๊ต์œก/์ •๋ณด ๋ชฉ์ ์œผ๋กœ๋งŒ ์ œ๊ณต๋˜๋ฉฐ, ๊ธˆ์œต, ํˆฌ์ž์„ธ ๋˜๋Š” ๊ฑฐ๋ž˜ ์กฐ์–ธ ๋ฐ ๊ถŒ๊ณ , ๊ฑฐ๋ž˜ ๊ฐ€๊ฒฉ ๊ธฐ๋ก, ๊ธˆ์œต ์ƒํ’ˆ ๋˜๋Š” ์›์น˜ ์•Š๋Š” ๊ธˆ์œต ํ”„๋กœ๋ชจ์…˜์˜ ๊ฑฐ๋ž˜ ์ œ์•ˆ ๋˜๋Š” ๊ถŒ์œ ๋ฅผ ํฌํ•จํ•˜์ง€ ์•Š์œผ๋ฉฐ, ํฌํ•จํ•ด์„œ๋„ ์•ˆ๋ฉ๋‹ˆ๋‹ค.

์ด ์›น์‚ฌ์ดํŠธ์— ํฌํ•จ๋œ ๋ชจ๋“  ์˜๊ฒฌ, ๋‰ด์Šค, ๋ฆฌ์„œ์น˜, ๋ถ„์„, ๊ฐ€๊ฒฉ, ๊ธฐํƒ€ ์ •๋ณด ๋˜๋Š” ์ œ3์ž ์‚ฌ์ดํŠธ์— ๋Œ€ํ•œ ๋งํฌ์™€ ๊ฐ™์ด XM์ด ์ค€๋น„ํ•˜๋Š” ์ฝ˜ํ…์ธ  ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ, ์ œ3์ž ์ฝ˜ํ…์ธ ๋Š” ์ผ๋ฐ˜ ์‹œ์žฅ ๋…ผํ‰์œผ๋กœ์„œ "ํ˜„์žฌ" ๊ธฐ์ค€์œผ๋กœ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ์—ฌ๊ฒจ์ง€์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ๋ชจ๋“  ์ฝ˜ํ…์ธ ๊ฐ€ ํˆฌ์ž ๋ฆฌ์„œ์น˜๋กœ ํ•ด์„๋˜๋Š” ๊ฒฝ์šฐ, ํˆฌ์ž ๋ฆฌ์„œ์น˜์˜ ๋…๋ฆฝ์„ฑ์„ ์ด‰์ง„ํ•˜๊ธฐ ์œ„ํ•ด ๊ณ ์•ˆ๋œ ๋ฒ•์  ์š”๊ฑด์— ๋”ฐ๋ผ ์ฝ˜ํ…์ธ ๊ฐ€ ์˜๋„๋˜์ง€ ์•Š์•˜์œผ๋ฉฐ, ์ค€๋น„๋˜์ง€ ์•Š์•˜๋‹ค๋Š” ์ ์„ ์ธ์ง€ํ•˜๊ณ  ๋™์˜ํ•ด์•ผ ํ•ฉ๋‹ˆ๋‹ค. ๋”ฐ๋ผ์„œ, ๊ด€๋ จ ๋ฒ•๋ฅ  ๋ฐ ๊ทœ์ •์— ๋”ฐ๋ฅธ ๋งˆ์ผ€ํŒ… ์ปค๋ฎค๋‹ˆ์ผ€์ด์…˜์ด๋ผ๊ณ  ๊ฐ„์ฃผ๋ฉ๋‹ˆ๋‹ค. ์—ฌ๊ธฐ์—์„œ ์ ‘๊ทผํ•  ์ˆ˜ ์žˆ๋Š” ์•ž์„œ ์–ธ๊ธ‰ํ•œ ์ •๋ณด์— ๋Œ€ํ•œ ๋น„๋…๋ฆฝ ํˆฌ์ž ๋ฆฌ์„œ์น˜ ๋ฐ ์œ„ํ—˜ ๊ฒฝ๊ณ  ์•Œ๋ฆผ์„ ์ฝ๊ณ , ์ดํ•ดํ•˜์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.

์šฐ๋ฆฌ๋Š” ์›น์‚ฌ์ดํŠธ์—์„œ ์ตœ๊ณ ์˜ ๊ฒฝํ—˜์„ ์ „ํ•ด๋“œ๋ฆฌ๊ธฐ ์œ„ํ•ด ์ฟ ํ‚ค๋ฅผ ์‚ฌ์šฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์ž์„ธํžˆ ์ฝ๊ฑฐ๋‚˜ ์ฟ ํ‚ค ์„ค์ •์„ ๋ณ€๊ฒฝํ•˜์„ธ์š”.

๋ฆฌ์Šคํฌ ๊ฒฝ๊ณ : ๊ณ ๊ฐ๋‹˜์˜ ์ž๋ณธ์ด ์œ„ํ—˜์— ๋…ธ์ถœ ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋ ˆ๋ฒ„๋ฆฌ์ง€ ์ƒํ’ˆ์€ ๋ชจ๋“  ๋ถ„๋“ค์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋‹น์‚ฌ์˜ ๋ฆฌ์Šคํฌ ๊ณต์‹œ๋ฅผ ์ฐธ๊ณ ํ•˜์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.